Log In
Print this Print this

pegylated proline-interferon alpha-2b

  Manage Alerts
Collapse Summary General Information
Company AOP Orphan Pharmaceuticals AG
DescriptionPegylated proline-interferon alpha-2b
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I/II
Standard IndicationMyeloproliferative disorder
Indication DetailsTreat polycythemia vera (PV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today